MDS-330: Outcomes of Imetelstat Therapy in Patients With Ring Sideroblast-Negative (RS-) Lower-Risk Myelodysplastic Syndromes (LR-MDS) From the Pooled IMerge Study Populations
Year: 2025
Type: conference-abstract
Authors: Valeria Santini, Uwe Platzbecker, Amer M. Zeidan, Mikkael A. Sekeres, Azra Raza, Moshe Mittelman, Sylvain Thépot, Rena Buckstein, Ulrich Germing, Yazan F. Madanat, María Díez-Campelo, David Valcárcel, Anna Jonášová, Souria Dougherty, Qi Xia, Libo Sun, Shyamala Navada, Faye Feller, Michael R. Savona, Rami S. Komrokji, Pierre Fenaux
Institutions: Azienda Ospedaliero-Universitaria Careggi, University of Florence, University Hospital Carl Gustav Carus, Nationales Centrum für Tumorerkrankungen Dresden, Technische Universität Dresden, Yale Cancer Center, Yale University, University of Miami, Sylvester Comprehensive Cancer Center, Columbia University Irving Medical Center, Tel Aviv University, Tel Aviv Sourasky Medical Center, Centre Hospitalier Universitaire d'Angers, Sunnybrook Health Science Centre, Sunnybrook Hospital, Odette Cancer Centre, Düsseldorf University Hospital, Heinrich Heine University Düsseldorf, Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Vall d'Hebron Hospital Universitari, Geron (United States), Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Moffitt Cancer Center, Université Paris Cité, Hôpital Saint-Louis
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4413782960